FDA Brief

Company record

Remel Europe Ltd.

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Remel Europe Ltd..

Recalls

ReportedClassFirmProduct and reason
Aug 19 Class II Remel Europe Ltd.
Device
Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics
Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.
Apr 29 Class II Remel Europe Ltd.
Device
Oxoid Agglutinating Sera, Salmonella 9-0 R30957301
Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.